Table 2.
Questionnaire/Time period (N)* | Regular RPA No. (%) | Disease-free survival |
Overall survival |
|||||
---|---|---|---|---|---|---|---|---|
Disease free No. (%) | Recurred No. (%) | P † | Alive No. (%) | Deceased No. (%) | P† | |||
Q1, before diagnosis (n = 1340) | Yes | 981 (73.2) | 765 (74.3) | 216 (69.7) | .11 | 828 (84.4) | 153 (80.8) | .11 |
No | 359 (26.8) | 265 (25.7) | 94 (30.3) | 290 (15.6) | 69 (19.2) | |||
Q2, during treatment (n = 1147) | Yes | 625 (54.5) | 493 (55.3) | 132 (51.6) | .29 | 528 (54.7) | 97 (53.3) | .72 |
No | 522 (45.5) | 398 (44.7) | 124 (48.4) | 437 (45.3) | 85 (46.7) | |||
Q3, 1 year after enrollment (n = 936) | Yes | 640 (68.4) | 519 (69.2) | 121 (65.1) | .28 | 560 (69.3) | 80 (62.5) | .12 |
No | 296 (31.6) | 231 (30.8) | 65 (34.9) | 248 (30.7) | 48 (37.5) | |||
Q4, 2 years after enrollment (n = 769) | Yes | 577 (75.1) | 483 (76.4) | 94 (68.6) | .06 | 512 (75.5) | 65 (71.4) | .39 |
No | 192 (24.9) | 149 (23.6) | 43 (31.4) | 166 (24.5) | 26 (28.6) |
*Total N for each questionnaire presented herein does not exactly coincide with Figure 1 because patients/deaths were excluded for the purposes of Landmark survival analyses for each successive exposure assessment and because 2 patients who completed Q3 did not complete Q2, and 5 patients who completed Q4 did not complete all prior questionnaires. RPA = recreational physical activity; Q = questionnaire.
values reflect two-sided χ2 test.